An interventional study of Whole (3.25%) cow's milk recommendation and Reduced (1%) fat milk in Obesity, Childhood, sponsored by The Hospital for Sick Children. Recruiting at 1 site in Canada. Open to participants aged 18 Months to 60 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-13.
Sponsored by The Hospital for Sick Children · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Pediatric Obesity by The Hospital for Sick Children — 2 open to participants now, 2 under way, none of them phase 3. Pediatric Obesity · The Hospital for Sick Children.
Among the 14 studies in Pediatric Obesity by The Hospital for Sick Children, this one is the 3rd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2020, is one of 10 with no phase, and was the 8th registered.
1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.
Browse Pediatric Obesity studies →2 of the 14 studies in Pediatric Obesity by The Hospital for Sick Children are open now, in 1 country. Recruiting first, the newest first:
The Hospital for Sick Children
Ages 1 days–1 wk · Healthy volunteers
By country, each count listing its studies:
Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.
This study: 18 Months to 60 Months · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2020.
This study's planned enrollment of 534 is above the median of 100 across 872 interventional studies indexed under Pediatric Obesity.
Median enrollment 99 across the 11 interventional studies, 52 across the 3 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
The Hospital for Sick Children is the lead sponsor of 579 studies on the registry; 81 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 14 studies in Pediatric Obesity by The Hospital for Sick Children, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Cow's milk is a dietary staple for children in North America. Though clinical guidelines suggest children transition from whole (3.25% fat) milk to reduced (1%) fat milk at age 2 years, recent epidemiological evidence supports a link between whole milk consumption and lower adiposity in children. The purpose of this trial is to determine which milk fat recommendation minimizes excess adiposity and optimizes child nutrition and development. CoMFORT will be a parallel group randomized controlled trial among children aged 2 to 4 years participating in the TARGet Kids! practice-based research network. Children will be randomized to receive one of two usual care nutritional recommendations: 1) a recommendation to consume whole milk, or 2) a recommendation to consume reduced (1%) fat milk. The primary outcome is Body Mass Index z-score (zBMI); secondary outcomes will be cognitive development (using the Ages and Stages Questionnaire), vitamin D stores (serum 25-hydroxyvitamin D), cardiometabolic health (glucose, hsCRP, non-HDL, LDL, triglyceride, HDL and total cholesterol, insulin, and diastolic and systolic blood pressure) and sugar sweetened beverage intake (measured by 24-hour dietary recall). Outcomes will be measured 24 months post-randomization and compared using ANCOVA, adjusting for baseline measures. This trial will contribute to nutrition policy for children in effort to reduce childhood obesity using a simple, inexpensive and scalable cow's milk fat intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Whole (3.25%) cow's milk recommendation
Other: Reduced (1%) fat milk
Children randomized to the whole milk recommendation will receive a recommendation a primary care recommendation to consume 500 mL of whole fat (3.25%) milk instead of transitioning to reduced fat (1%) milk at 2 years of age. The primary care physician will verbally make this recommendation during the recruitment well-child visit. Parents will also be reminded bi-monthly by phone calls made by a research assistant. Children in the whole milk recommendation group will be provided with the same age-appropriate nutritional recommendations as children in the reduced fat recommendation group as part of routine healthcare according to the Rourke Baby Record.
Children randomized to the reduced fat group will receive a primary care recommendation to transition from whole milk to 500 mL reduced fat (1%) milk daily once the child is two years of age (consistent with current guidelines). The physician will verbally make this recommendation during the recruitment well-child visit. Parents will also be reminded bi-monthly by phone calls made by a research assistant. Children who receive the reduced fat recommendation will be provided with the same age-appropriate nutritional recommendations as children who receive the whole fat recommendation as part of routine healthcare according to the Rourke Baby Record.
weight
kilograms; measured using a Healthometer stadiometer
Time frame: Measured 24 months post-study entry
height
metres; measured using a Healthometer statiometer
Time frame: Measured 24 months post-study entry
body mass index z-score (zBMI)
BMI calculated by weight (kg)/height (m\^2); zBMI determined according to the World Health Organization guidelines
Time frame: Measured 24 months post-study entry
serum 25-hydroxyvitamin D
measured in nmol/L
Time frame: Measured 24 months post-study entry
serum glucose
measured in mmol/L
Time frame: measured 24 months post-study entry
blood pressure
systolic and diastolic
Time frame: measured 24 months post-study entry
serum insulin
measured in mmol/L
Time frame: measured 24 months post-study entry
serum triglycerides
measured in mmol/L
Time frame: measured 24 months post-study entry
serum total cholesterol
measured in mmol/L
Time frame: measured 24 months post-study entry
serum high density lipoprotein cholesterol
measured in mmol/L
Time frame: measured 24 months post-study entry
serum low density lipoprotein cholesterol
measured in mmol/L
Time frame: measured 24 months post-study entry
serum non-high density lipoprotein cholesterol
measured in mmol/L
Time frame: measured 24 months post-study entry
serum highly sensitive c-reactive protein
measured in mg/L
Time frame: measured 24 months post-study entry
height z-score
measured by a trained research assistant according to the World Health Organization guidelines
Time frame: measured 24 months post-study entry
waist circumference
measured by a trained research assistant
Time frame: measured 24 months post-study entry
lean body mass
measured in kg, % body weight
Time frame: measured 24 months post-study entry
fat mass
measured in kg, % body weight
Time frame: measured 24 months post-study entry
school readiness
measured using the Early Development Instrument (EDI); children scoring at or below the 25th percentile of children in their province are considered at risk for continuing on the low achievement and health trajectory, and are more likely to fall behind in academic achievement in later grades
Time frame: measured 24 months post-study entry
cognitive development
measured using the Ages and Stages Questionnaire (ASQ)
Time frame: measured 24 months post-study entry
dietary intake
measured using the Automated Multiple Pass Self Administered 24 hour recall (ASA24) tool
Time frame: measured 24 months post-study entry
carotid intima media thickness (cIMT)
measured by ultrasound
Time frame: measured 24 months post-study entry
restrained and emotional eating
measured using the 3-factor eating questionnaire
Time frame: measured 24 months post-study entry
nutritional risk
measured using NutriSTEP preschooler
Time frame: measured 24 months post-study entry
physical activity (minutes per day)
questionnaire data and accelerometry
Time frame: measured 24 months post-study entry
sleep time (hours per night)
questionnaire data and accelerometry
Time frame: measured 24 months post-study entry
healthcare service utilization
information accessed through OHIP linkage
Time frame: measured 24 months post-study entry
upper respiratory tract infection incidence
information accessed through OHIP linkage
Time frame: measured 24 months post-study entry
growth trajectories
zBMI growth rates
Time frame: measured 24 months post-study entry
head circumference
measured by a trained research assistant
Time frame: measured 24 months post-study entry
cost effectiveness
All costs, parameter estimates and ranges will be derived from study data and will be obtained using medical record extraction. Publicly available Ontario costing sources will be used to cost resource utilisation parameters.
Time frame: measured 24 months post-study entry
Plan to share: No
Started Jan 2020 (actual). Primary completion is estimated for Dec 2024, 59 months after the start.
Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 59 months is above that.
Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Hospital for Sick Children →